https://adisinsight.springer.com/drugs/800059994?error=cookies_not_supported&code=a7827a8d-17a7-426d-8125-02b245299160
PBAL 05 - AdisInsight
PBAL 05, a gene therapy is being developed by Passage Bio under licensing agreement with University of Pennsylvania for the treatment of amyotrophic lateral
adisinsight